Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men

• Autor(a) principal: Loures,Marco Antônio R.
• Data de Publicação: 2017
• Outros Autores: Zerbini,Cristiano Augusto F., Danowski,Jaime S., Pereira,Rosa Maria R., Moreira,Caio, Paula,Ana Patrícia de, Castro,Charlles Heldan M., Szejnfeld,Vera Lúcia, Mendonça,Laura Maria C., Radominiski,Sebastião C., Bezerra,Mailze C., Simões,Ricardo, Bernardo,Wanderley M.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista Brasileira de Reumatologia (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000800009
• topic: Osteoporosis; Men; Guidelines; Diagnosis; Therapy

Abstract Osteoporosis, a metabolic disease characterized by low bone mass, deterioration of the bone tissue microarchitecture and increased susceptibility to fractures, is commonly regarded as a women's health problem. This point of view is based on the fact that compared with men, women have lower bone mineral density and longer lifespans and lose bone mass faster, especially after menopause, due to a marked decrease in serum estrogen levels. However, in the last 20 years, osteoporosis in men has become recognized as a public health problem due to the occurrence of an increasingly higher number of fragility fractures. Approximately 30% of all hip fractures occur in men. Recent studies show that the probability of fracture due to hip, vertebral or wrist fragility in Caucasian men older than fifty years, for the rest of their lives, is approximately 13% versus a 40% probability of fragility fractures in women. Men show bone mass loss and fractures later than women. Although older men have a higher risk of fracture, approximately half of all hip fractures occur before the age of 80. Life expectancy is increasing for both sexes in Brazil and worldwide, albeit at a higher rate for men than for women. This Guideline was based on a systematic review of the literature on the prevalence, etiology, diagnosis and treatment of osteoporosis in men.